According to classification of AKIP1 low/high+/high++/high+++ expression, increased grade of AKIP1 expression was correlated with larger tumor size ( P = .003), extrathyroidal invasion ( P < .001), higher pT stage ( P < .001), and it showed a trend to be positively correlated with pN stage ( P = .091) as well as pTNM stage ( P = .060) (but without statistical significance), while it was not correlated with age ( P = .437) or gender ( P = .492). 3.4.
In contrast, in the N1 + 2 group, chemotherapy was significantly associated with a better OS ( p = 0.042) and showed a trend toward a better DSS ( p = 0.091) compared with no chemotherapy ( Figure 1 ).
As shown in Table 6 , the severity of maternal asthma exacerbation showed a trend toward an increased risk of fetal complications (β = 0.679; OR 1.97; 95%CI 0.90-4.34; p=0.091), while systemic corticosteroid therapy demonstrated a protective trend (β = -1.602; OR 0.20; 95%CI 0.03-1.20; p=0.079).
Responses to the doublet stimulus at 10 Hz showed a trend toward an increase following resistance exercise training ( p = 0.091) with a medium effect size in the control group (partial η 2 = 0.349), but the effect sizes were small in the 36°C group (partial η 2 = 0.065) and the 40°C group (partial η 2 = 0.168).
Fecal propionic and butyric acid levels showed a trend towards lower concentrations in people with T2D compared either to NonDM ( p = 0.091) and preDM ( p = 0.090), respectively; however, these differences did not reach statistical significance.
However, the model for Group B showed a trend toward significance ( p = 0.091), raising the possibility that in children with longstanding celiac disease, higher osteoprotegerin levels may be modestly associated with delayed skeletal maturation.
Relationship between the BMI and NAT BP ND The BMI and BP ND showed a trend towards parabolic relation forming a U-shaped graph in the hypothalamus ( Figure 6 ; r 2 = 0.042, p = 0.091).
Despite the individual-level improvements, COST only showed a trend for improvement ( P = 0.091) at follow-up.
Stroke patients had significantly lower HI ( p = 0.049) and showed a trend towards a higher AI/HI ratio ( p = 0.091).
In multivariate analyses, FGF-21 showed a trend toward a positive correlation with glucose disposal that did not reach statistical significance (standardized beta = 0.476, p = 0.091).
The EBV-positive DLBCL patients with early interruption of R-CHOP chemotherapy showed a trend toward a high EBV DNA titer (≥1000 copies/mL; P = 0.091).
Vasomotor-Associated Side Effects (Hot Flashes) In univariate analysis, individuals homozygous for UGT1A4 rs11888492 showed a trend toward a reduced risk of hot flashes (OR = 0.24; 95% CI = 0.05–1.25; p = 0.091); however, this association did not persist in the multivariate model.
Moreover, higher protein carbonylation levels showed a trend toward reduced survival ( p = 0.091).
Analysis of the primary endpoint 6MWD with O 2 administration showed a trend in improvement for all patients receiving LTOT (all patients: 35 ± 81.6 m improvement by LTOT; p = 0.091) and for the intervention vs. control group (O 2 group 47.8 ± 88.9 m vs. control − 11.5 ± 21.4 m).
However, the dAM+sBCL treatment group showed a trend towards significance ( p = 0.091), indicating potential benefits over time.
Even though not statistically significant, NR5A2- rs2816945 showed a trend (p = 0.091) with the G allele associated with increased risk.
Transgenic rats showed a trend toward fewer correct choices than Wt rats ( P = 0.091, repeated measures ANOVA; Figure 4 E).
Patients with dMMR CRC had a higher median pre-operative CRP ( P <0.001) and neutrophil count ( P <0.05), and showed a trend towards a higher median platelet count ( P =0.091).
Comparison of clinical outcomes between patients with KMT2A -PTD <0.1% (group 1), ≥0.1% but <1% (group 2), and ≥1% (group 3) before HID HSCT Patients in group 3 had a higher 2-year cumulative incidence of relapse after HID HSCT (36.4%, 95% confidence interval [CI]: 6.3%–66.5%) compared with those in group 1 (7.7%, 95% CI: 0.0%–16.2%) ( P = .016), and showed a trend of higher 2-year cumulative incidence of relapse compared with those in group 2 (7.1%, 95% CI: 0.0%–21.1%) ( P = .091) ( Fig. 3 A ).
All measures showed a trend for cognitive impairment at stage III ( p < 0.091) with robust group differences emerging at Braak stages IV to VI ( p < 0.001).
Patients who developed an infection after definitive closure had a shorter median time to initial debridement (154 vs 214 minutes, P = 0.033) and showed a trend toward greater ambulatory aid use at follow-up (53% vs 30%, P = 0.091).
In adjusted analyses, HIV-positive recipients showed a trend toward increased acute rejection rate in the deceased-donor cohort (aOR = 1.53 [0.94-2.50]; P = 0.091; Table S12 [ SDC , https://links.lww.com/TP/D333 ]).
Video distraction showed a trend toward anxiety reduction that did not reach statistical significance ( p = 0.091), while producing a significant reduction in pain ( p = 0.027).
61%, p = 0.004) and showed a trend toward higher bacteremia (19% vs. 5%, p = 0.091), compared to patients without these enzymes [ 51 ].
In multivariate linear regression models, only age remained significant (β=.268, p=0.004) for PWV while torsion showed a trend for significance (β=.178, p=0.091).